Bioasis Technologies (OTC:BIOAF) Stock, Quote.Headers.trade-ideas

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Biotech

Penny Stocks

Short Ideas

Trading Ideas

General

BIOAF

On Monday, shares of Bioasis Tech Inc (OTC: BIOAF) experienced volatile short activity. After the activity, the stock price went down -3.23% to $0.006.

The overall sentiment for BIOAF has been Bearish.

Short Volatility Alert: Bioasis Tech Inc

By John Vandermosten, CFA

OTC:BIOAF

READ THE FULL BIOAF RESEARCH REPORT

BIOAF: FY 2022 Results and Valuation Update

Earnings

Large Cap

News

Health Care

Financing

Offerings

Contracts

Small Cap

Movers

ACLX

BCDA

CYCC

EIGR

FOLD

GMAB

NEXI

PDSB

PIRS

RHHBY

TCON

TFFP

TRVN

VERU

XCUR

XERS

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly&#39;s COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine

BIOASIS TECHNOLOGIES INC by Bioasis Technologies Inc.

Bioasis Technologies

Comments

Bioasis Technologies

Bioasis Technologies (OTC:BIOAF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell